Search

Pharming Group NV

Open

1.178 0.86

Overview

Share price change

24h

Current

Min

1.157

Max

1.177

Key metrics

By Trading Economics

Income

21M

23M

Sales

28M

118M

P/E

Sector Avg

38.283

68.089

EPS

0.03

Profit margin

19.048

Employees

407

EBITDA

26M

31M

Market Stats

By TradingEconomics

Market Cap

67M

813M

Previous open

0.32

Previous close

1.178

Pharming Group NV Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

10 lis 2026, 23:56 UTC

State Street Corporation's shares have advanced modestly in after-market trading, continuing a trend of higher closes over the past four sessions.

10 lis 2026, 23:56 UTC

In after-market trading, Quest Diagnostics Inc is effectively unchanged since Tuesday's close, remaining flat within a narrow band above its 20-day moving average.

10 lis 2026, 23:56 UTC

KKR & Co Inc is trading modestly lower in after-market hours, following a decline from a low shortly after the market reopened.

10 lis 2026, 23:56 UTC

Travelers Companies, Inc. shares are lower in after-market trading, having retraced from an initial rise to near the low end of their after-market range.

10 lis 2026, 23:56 UTC

Snowflake Inc. is seeing a slight increase in after-market trading, remaining roughly flat since Tuesday's close and 4.74% below its 20-day moving average.

10 lis 2026, 23:56 UTC

APA Corporation shares are modestly higher in after-market trading, recovering slightly from earlier lows, though still below the 20-day moving average.

10 lis 2026, 23:56 UTC

Fox Corporation shares have declined modestly in after-market trading, reflecting unusual weakness since Tuesday's close while remaining above its 20-day moving average.

10 lis 2026, 23:53 UTC

South Korea's October unemployment rate drops to 2.5%, exceeding expectations and signaling strong labor market recovery.

10 lis 2026, 23:53 UTC

Federal Reserve's Bowman signals potential interest rate hikes amid persistent inflation concerns, with Goldman Sachs adjusting forecasts for December and March increases.

10 lis 2026, 23:53 UTC

Australia's Q3 Investment Lending Data Release on November 11 Expected Amid Concerns of Continued Declines in Home Loans and Economic Sentiment.

10 lis 2026, 23:53 UTC

Japan's Upcoming Export Data Release Sparks Cautious Optimism Amid Mixed Economic Signals

10 lis 2026, 23:53 UTC

Japan's Upcoming Balance of Trade Data on November 17 Sparks Caution Amid Mixed Economic Signals and High Import Costs.

10 lis 2026, 23:52 UTC

Waste Management Inc. is trading lower in after-market hours, reaching its lowest point since Tuesday's close.

10 lis 2026, 23:51 UTC

GitLab Inc. is declining in after-market trading, having retraced from a brief recovery and remaining significantly below its 20-day moving average.

10 lis 2026, 23:51 UTC

ITT Inc. is trading modestly higher in after-market hours, reaching its highest level of the day while remaining above its 20-day moving average.

10 lis 2026, 23:51 UTC

News

Electromed, Inc. reported fiscal Q1 2027 revenues of $18.7 million, missing analyst expectations of $19.27 million, while EPS of $0.32 exceeded estimates by $0.03.

10 lis 2026, 23:51 UTC

United Therapeutics Corporation shares advanced during after-market hours on Tuesday, continuing a trend of higher daily closes since the previous session.

10 lis 2026, 23:51 UTC

Blue Owl Capital Corp is declining in after-market trading, moving lower since Tuesday's close.

10 lis 2026, 23:51 UTC

Papa John's International Inc is advancing in after-market trading, rising significantly since Tuesday's close and positioned above its 20-day moving average.

10 lis 2026, 23:51 UTC

CLEAR Secure, Inc. is moving higher in after-market trading, reacting to inflation data and expectations for a potential Federal Reserve rate hike in December.

10 lis 2026, 23:51 UTC

PepsiCo, Inc. is trading modestly lower in after-market hours, having retraced from a peak and reaching its lowest point since Tuesday's close.

10 lis 2026, 23:51 UTC

Correlated Moves

Sterling Infrastructure, Inc. is advancing in after-market trading, amid a broader market uptrend and a sharp rise in the Leverage Shares 2X Long CRWV Daily ETF (CRWG).

10 lis 2026, 23:51 UTC

Social Media

Constellation Energy Corp shares advanced modestly in after-market trading, following CEO Joseph Dominguez's comments on U.S. power capacity and grid energy availability.

10 lis 2026, 23:51 UTC

Modine Manufacturing Company shares are advancing in after-market trading.

10 lis 2026, 23:51 UTC

Metropolitan Bank Holding Corp is declining in after-market trading, reaching its lowest point shortly after the market closed while remaining above its 20-day moving average.

10 lis 2026, 23:51 UTC

Entergy Corp is trading lower in after-market hours, nearly 1% below Tuesday's close.

10 lis 2026, 23:51 UTC

Correlated Moves
News

Seagate Technology Holdings PLC launched the FireCuda Forge, its first hard drive using the Alkemi platform, targeting gamers and content creators.

10 lis 2026, 23:51 UTC

VF Corp shares are trading modestly lower in after-market hours, having pulled back from a brief peak earlier in the session that matched Tuesday's close.

10 lis 2026, 23:51 UTC

VICI Properties Inc. is trading higher in after-hours, maintaining a position above its 20-day moving average and near the upper end of its one-month range.

10 lis 2026, 23:51 UTC

News

Legend Biotech reported Q3 2026 net trade sales of CARVYKTI at approximately $710 million, with adjusted net income of $55.6 million, advancing in after-market trading.

Peer Comparison

Price change

Pharming Group NV Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
help-icon Live chat